IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v14y2023i1d10.1038_s41467-023-37359-2.html
   My bibliography  Save this article

Safe drugs with high potential to block malaria transmission revealed by a spleen-mimetic screening

Author

Listed:
  • Mario Carucci

    (Université Paris Cité, Inserm, UMR-1134, Biologie Intégré du Globule Rouge)

  • Julien Duez

    (SYNSIGHT)

  • Joel Tarning

    (Mahidol University
    University of Oxford)

  • Irene García-Barbazán

    (Mycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III)

  • Aurélie Fricot-Monsinjon

    (Université Paris Cité, Inserm, UMR-1134, Biologie Intégré du Globule Rouge)

  • Abdoulaye Sissoko

    (Université Paris Cité, Inserm, UMR-1134, Biologie Intégré du Globule Rouge)

  • Lucie Dumas

    (Université Paris Cité, Inserm, UMR-1134, Biologie Intégré du Globule Rouge)

  • Pablo Gamallo

    (Global Health Medicines R&D, GlaxoSmith Kline (GSK))

  • Babette Beher

    (Université Paris Cité, Inserm, UMR-1134, Biologie Intégré du Globule Rouge)

  • Pascal Amireault

    (Université Paris Cité, Inserm, UMR-1134, Biologie Intégré du Globule Rouge
    Laboratory of cellular and molecular mechanisms of hematological disorders and therapeutic implications, INSERM)

  • Michael Dussiot

    (Laboratory of cellular and molecular mechanisms of hematological disorders and therapeutic implications, INSERM
    Laboratoire d’Excellence GR-Ex)

  • Ming Dao

    (Massachusetts Institute of Technology)

  • Mitchell V. Hull

    (Calibr, a division of The Scripps Research Institute)

  • Case W. McNamara

    (Calibr, a division of The Scripps Research Institute)

  • Camille Roussel

    (Université Paris Cité, Inserm, UMR-1134, Biologie Intégré du Globule Rouge
    Laboratoire d’Excellence GR-Ex
    Laboratoire d’Hématologie générale, Hôpital Universitaire Necker Enfants Malades, Assistance Publique–Hôpitaux de Paris (AP-HP))

  • Papa Alioune Ndour

    (Université Paris Cité, Inserm, UMR-1134, Biologie Intégré du Globule Rouge)

  • Laura Maria Sanz

    (Global Health Medicines R&D, GlaxoSmith Kline (GSK))

  • Francisco Javier Gamo

    (Global Health Medicines R&D, GlaxoSmith Kline (GSK))

  • Pierre Buffet

    (Université Paris Cité, Inserm, UMR-1134, Biologie Intégré du Globule Rouge
    AP-HP, Necker Hospital
    Centre Médical de l’Institut Pasteur (CMIP), Institut Pasteur)

Abstract

Malaria parasites like Plasmodium falciparum multiply in red blood cells (RBC), which are cleared from the bloodstream by the spleen when their deformability is altered. Drug-induced stiffening of Plasmodium falciparum-infected RBC should therefore induce their elimination from the bloodstream. Here, based on this original mechanical approach, we identify safe drugs with strong potential to block the malaria transmission. By screening 13 555 compounds with spleen-mimetic microfilters, we identified 82 that target circulating transmissible form of P. falciparum. NITD609, an orally administered PfATPase inhibitor with known effects on P. falciparum, killed and stiffened transmission stages in vitro at nanomolar concentrations. Short exposures to TD-6450, an orally-administered NS5A hepatitis C virus inhibitor, stiffened transmission parasite stages and killed asexual stages in vitro at high nanomolar concentrations. A Phase 1 study in humans with a primary safety outcome and a secondary pharmacokinetics outcome ( https://clinicaltrials.gov , ID: NCT02022306) showed no severe adverse events either with single or multiple doses. Pharmacokinetic modelling showed that these concentrations can be reached in the plasma of subjects receiving short courses of TD-6450. This physiologically relevant screen identified multiple mechanisms of action, and safe drugs with strong potential as malaria transmission-blocking agents which could be rapidly tested in clinical trials.

Suggested Citation

  • Mario Carucci & Julien Duez & Joel Tarning & Irene García-Barbazán & Aurélie Fricot-Monsinjon & Abdoulaye Sissoko & Lucie Dumas & Pablo Gamallo & Babette Beher & Pascal Amireault & Michael Dussiot & M, 2023. "Safe drugs with high potential to block malaria transmission revealed by a spleen-mimetic screening," Nature Communications, Nature, vol. 14(1), pages 1-16, December.
  • Handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-37359-2
    DOI: 10.1038/s41467-023-37359-2
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-023-37359-2
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-023-37359-2?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Prasanna Jagannathan & Abel Kakuru, 2022. "Malaria in 2022: Increasing challenges, cautious optimism," Nature Communications, Nature, vol. 13(1), pages 1-3, December.
    2. Michael J. Delves & Celia Miguel-Blanco & Holly Matthews & Irene Molina & Andrea Ruecker & Sabrina Yahiya & Ursula Straschil & Matthew Abraham & María Luisa León & Oliver J. Fischer & Ainoa Rueda-Zubi, 2018. "A high throughput screen for next-generation leads targeting malaria parasite transmission," Nature Communications, Nature, vol. 9(1), pages 1-13, December.
    3. Akhil B. Vaidya & Joanne M. Morrisey & Zhongsheng Zhang & Sudipta Das & Thomas M. Daly & Thomas D. Otto & Natalie J. Spillman & Matthew Wyvratt & Peter Siegl & Jutta Marfurt & Grennady Wirjanata & Bon, 2014. "Pyrazoleamide compounds are potent antimalarials that target Na+ homeostasis in intraerythrocytic Plasmodium falciparum," Nature Communications, Nature, vol. 5(1), pages 1-10, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Deyun Qiu & Jinxin V. Pei & James E. O. Rosling & Vandana Thathy & Dongdi Li & Yi Xue & John D. Tanner & Jocelyn Sietsma Penington & Yi Tong Vincent Aw & Jessica Yi Han Aw & Guoyue Xu & Abhai K. Tripa, 2022. "A G358S mutation in the Plasmodium falciparum Na+ pump PfATP4 confers clinically-relevant resistance to cipargamin," Nature Communications, Nature, vol. 13(1), pages 1-18, December.
    2. Madeline G. Dans & Coralie Boulet & Gabrielle M. Watson & William Nguyen & Jerzy M. Dziekan & Cindy Evelyn & Kitsanapong Reaksudsan & Somya Mehra & Zahra Razook & Niall D. Geoghegan & Michael J. Mlodz, 2024. "Aryl amino acetamides prevent Plasmodium falciparum ring development via targeting the lipid-transfer protein PfSTART1," Nature Communications, Nature, vol. 15(1), pages 1-19, December.
    3. Xinyue Du & Baiyang Ren & Chang Li & Qi Li & Shuo Kan & Xin Wang & Wenjuan Bai & Chenyun Wu & Kokouvi Kassegne & Huibo Yan & Xiaoyin Niu & Min Yan & Wenyue Xu & Samuel C. Wassmer & Jing Wang & Guangji, 2024. "PRL2 regulates neutrophil extracellular trap formation which contributes to severe malaria and acute lung injury," Nature Communications, Nature, vol. 15(1), pages 1-14, December.
    4. Laura E. Vries & Patrick A. M. Jansen & Catalina Barcelo & Justin Munro & Julie M. J. Verhoef & Charisse Flerida A. Pasaje & Kelly Rubiano & Josefine Striepen & Nada Abla & Luuk Berning & Judith M. Bo, 2022. "Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    5. Jiahong Li & Gerald J. Shami & Ellie Cho & Boyin Liu & Eric Hanssen & Matthew W. A. Dixon & Leann Tilley, 2022. "Repurposing the mitotic machinery to drive cellular elongation and chromatin reorganisation in Plasmodium falciparum gametocytes," Nature Communications, Nature, vol. 13(1), pages 1-15, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-37359-2. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.